Physician profile
Tara Paternoster
NPI 1720210792
$1,326.73
in general payments reported to CMS, 2019-2025
18 companies · $642 in 2025
The $642 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.15 · 2022: $86.62 · 2023: $292 · 2024: $271 · 2025: $642.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,203.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $246.94 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $236.95 | 2023-2025 | |
| Verity Pharmaceuticals INC. | $103.99 | 2024-2025 | Trelstar |
| Janssen Biotech, INC. | $101.65 | 2023-2025 | Erleada, Akeega |
| Ferring Pharmaceuticals INC. | $87.17 | 2024-2025 | Adstiladrin |
| Sumitomo Pharma America, INC. | $85.14 | 2023 | Gemtesa |
| Abbott Laboratories | $71.02 | 2021-2022 | |
| Boston Scientific Corporation | $51.75 | 2021-2022 | |
| Urogen Pharma, INC. | $51.65 | 2024-2025 | |
| Abbvie INC. | $51.64 | 2023-2024 | |
| Sun Pharmaceutical Industries INC. | $48.23 | 2024 | |
| Astellas Pharma US INC | $47.82 | 2023-2024 | Myrbetriq, Xtandi |
| Endo USA, INC. | $44.46 | 2025 | Xiaflex |
| Immunitybio, INC. | $24.28 | 2025 | |
| Halozyme INC | $23.99 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $18.24 | 2025 | Xyosted |
| Accord Healthcare, INC. | $16.23 | 2023 | |
| Azurity Pharmaceuticals, INC. | $15.58 | 2025 | Azmiro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Paternoster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.